文献速递慢性肾脏病血液净化与透析

肾衰竭风险方程对血管通路规划的临床影响

Clinical impact of the Kidney Failure Risk Equation for vascular access planning.
PubMed 文献 · Nephrol Dial Transplant · 2024-01-01

KFRE>40%和>50%在避免不必要手术方面净获益最大,12个月特异性最高为KFRE>50%的94.5%,2年阳性预测值KFRE>50%为71.5。

要点

  • KFRE>40%和>50%较eGFR<15更适用于血管通路规划。
  • 12个月特异性KFRE>50%达94.5%,敏感性KFRE>30%为79.3%。
  • 瑞典54%转诊患者以CVC起始血透,其中60%在KRT前超过KFRE>40%。

核心结论

  • 使用KFRE>40%和KFRE>50%规划血管通路的效用高于传统eGFR<15 mL/min/1.73 m2阈值。

主要发现

  • 12个月KRT启动特异性:KFRE>50%为94.5%(95%CI 94.3-94.7),KFRE>40%为90.0%(95%CI 89.7-90.3)。
  • 12个月KRT启动敏感性:KFRE>30%为79.3%(95%CI 78.2-80.3),eGFR<15为81.2%(95%CI 80.2-82.2)。
  • 2年阳性预测值:KFRE>50%为71.5(95%CI 70.2-72.8),KFRE>40%为61.7(95%CI 60.4-63.0),eGFR<15为47.2(95%CI 46.1-48.3)。
  • 决策曲线分析显示,避免不必要手术时,2年KFRE>40%和12个月KFRE>50%净获益最大。
  • 瑞典54%转诊患者以CVC起始血透,其中仅5%在起始前>6个月有AV通路手术;60%的CVC患者在中位0.8年(IQR 0.4-1.5)前超过KFRE>40%。

关键数值与推荐

  • 12个月特异性:KFRE>50%为94.5%(95%CI 94.3-94.7),KFRE>40%为90.0%(95%CI 89.7-90.3)。
  • 12个月敏感性:KFRE>30%为79.3%(95%CI 78.2-80.3),eGFR<15为81.2%(95%CI 80.2-82.2)。
  • 2年阳性预测值:KFRE>50%为71.5(95%CI 70.2-72.8),KFRE>40%为61.7%(95%CI 60.4-63.0),eGFR<15为47.2(95%CI 46.1-48.3)。

临床怎么用

  • 血管通路转诊可优先采用KFRE>40%(2年)或KFRE>50%(12个月)阈值以平衡手术获益与风险。
  • 对超过KFRE>40%的患者应提前规划AV通路,避免以CVC起始透析。

局限性

  • 研究基于瑞典登记数据,外推至其他人群需谨慎。
  • 原文未报告决策曲线分析的具体净获益数值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Risk-based thresholds for arteriovenous (AV) access creation has been proposed to aid vascular access planning. We aimed to assess the clinical impact of implementing the Kidney Failure Risk Equation (KFRE) for vascular access referral. METHODS: A total of 16 102 nephrology-referred chronic kidney disease (CKD) patients from the Swedish Renal Registry 2008-18 were included. The KFRE was calculated repeatedly, and the timing was identified for when the KFRE risk exceeded several pre-defined thresholds and/or the estimated glomerular filtration rate was <15 mL/min/1.73 m2 (eGFR15). To assess the utility of the KFRE/eGFR thresholds, cumulative incidence curves of kidney replacement therapy (KRT) or death, and decision-curve analyses were computed at 6 and 12 months, and 2 years. The potential impact of using the different thresholds was illustrated by an example from the Swedish access registry. RESULTS: The 12-month specificity for KRT initiation was highest for KFRE >50% {94.5 [95% confidence interval (CI) 94.3-94.7]} followed by KFRE >40% [90.0 (95% CI 89.7-90.3)], while sensitivity was highest for KFRE >30% [79.3 (95% CI 78.2-80.3)] and eGFR <15 mL/min/1.73 m2 [81.2 (95% CI 80.2-82.2)]. The 2-year positive predictive value was 71.5 (95% CI 70.2-72.8), 61.7 (95% CI 60.4-63.0) and 47.2 (95% CI 46.1-48.3) for KFRE >50%, KFRE >40% and eGFR <15, respectively. Decision curve analyses suggested the largest net benefit for KFRE >40% over 2 years and KFRE >50% over 12 months when it is important to avoid the harm of possibly unnecessary surgery. In Sweden, 54% of nephrology-referred patients started hemodialysis in a central venous catheter (CVC), of whom only 5% had AV access surgery >6 months before initiation. Sixty percent of the CVC patients exceeded KFRE >40% a median of 0.8 years (interquartile range 0.4-1.5) before KRT initiation. CONCLUSIONS: The utility of using KFRE >40% and KFRE >50% is higher compared with the more traditionally used eGFR threshold <15 mL/min/1.73 m2 for vascular access planning.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Hahn Lundström U, Ramspek CL, Dekker FW, et al. Clinical impact of the Kidney Failure Risk Equation for vascular access planning. Nephrol Dial Transplant. 2024. PMID: 38486367. doi:10.1093/ndt/gfae064

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。